CHANHASSEN, Minn., Oct. 3, 2012 /PRNewswire-iReach/ -- Wound Care Technologies, Inc., a Minnesota based emerging medical technology company focused on the commercialization of external tissue expansion devices, announced today a new study published in the October 2012 issue of the Annals of Plastic Surgery.
The study by surgeons from Walter Reed National Military Medical Center in Bethesda, Maryland entitled "Soft Tissue Injury Management With a Continuous External Tissue Expander" highlights how surgeons can use the DermaClose® RC external tissue expander as a valuable adjunct in achieving definitive wound closure. The results of this study revealed that with a mean wound size of 263 cm2 overall time to wound coverage ranged from 1 to 6 days, with mean time to wound coverage being 4.4 days. In this study 86% of the wounds were able to undergo delayed primary closure.
Furthermore, this peer reviewed article states that external tissue expansion can often aid in successful delayed primary closure of certain soft tissue wounds, has low associated morbidities, and can reduce the need for more complex or morbid procedures when used properly. The authors propose an algorithm for the use of continuous external tissue expansion system to achieve effective and successful wound closure, while potentially reducing the need for increased donor-site morbidities associated with more complex or larger reconstruction measures.
Paul J. Anderson, President and CEO of Wound Care Technologies, said, "This article continues to confirm the effectiveness of the DermaClose® continuous external tissue expander in the treatment of large, complex wounds. The reduction in time to wound closure is significant in that it creates an environment for fewer patient complications, reduced costs and increases the potential for improved patient care."
About DermaClose® RC
DermaClose® RC is a continuous external tissue expander that facilitates rapid tissue movement to reduce or re-approximate wounds. The first-of-its-kind device utilizes skin anchors and a tension controller that applies a continuous controlled dynamic pulling force and does not require additional tightening after initial application. The tension will be maintained from hours to days until desired amount of expanded tissue is achieved and the device is removed.
About Wound Care Technologies, Inc.
Wound Care Technologies, Inc. (www.woundcaretech.com) is an emerging medical device company focused on the commercialization of its novel continuous external tissue expansion technology. The DermaClose® RC is the companies' initial product and is currently marketed in the United States.
Wound Care Technologies, Inc.; 1851 Lake Drive West, Suite 450; Chanhassen, MN 55317
Phone: 952-937-2804 Fax: 312-327-4448
Media Contact: Paul Anderson Wound Care Technologies, Inc., 952-937-2804, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Wound Care Technologies, Inc.